Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SNX10 antisense RNA 1 (SNX10-AS1) is a long non-coding antisense RNA transcribed from the opposite strand to the SNX10 gene at chromosome 7p15.2[4]. Like other antisense lncRNAs, SNX10-AS1 is believed to regulate the expression of its sense gene (SNX10), possibly through direct interaction with the sense mRNA, influencing RNA stability, transcription, or chromatin state[5][2]. There are no known drugs or clinical interventions directly targeting SNX10-AS1, and its precise biological or disease functions remain largely uncharacterized. Its molecular properties and potential regulatory functions are inferred from its classification among antisense lncRNAs, which are increasingly recognized as important regulators of gene expression and sometimes implicated in disease processes[5][2][4]. There are no explicit links to major diseases or validated use as a therapeutic or biomarker target at this time.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on SNX10 antisense RNA 1 (SNX10-AS1).